Latest market headlines for SHILPAMED on Terminal.
10-Sept-2026 14:59:41
• FTF Pharma Private Limited, a wholly owned subsidiary of Shilpa Medicare Limited, is subject to Corporate Insolvency Resolution Process (CIRP) as ordered by…
18-Aug-2026 16:11:38
• Voluntary recall initiated on July 29, 2026, at the retail/hospital level for Pemetrexed Injection 100 mg/10 mL and 500 mg/50 mL (Pemetri RTU™). • Recall cov…
30-Jun-2026 10:23:59
• Shilpa Biologicals Pvt Ltd, a wholly owned subsidiary, enters into a co-development and supply agreement with Orion Corporation, Finland. • The agreement is…
24-Jun-2026 17:45:40
• Shilpa Biologicals Pvt. Ltd. and Sartorius Stedim India Pvt. Ltd. entered into a settlement agreement before the Hon'ble XI Addl. City Civil and Sessions Cou…
24-Jun-2026 08:58:37
• Shilpa Biologicals Ltd, a subsidiary, commissioned a state-of-the-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility in Dharwad. • The facility is…